2021-12-31-accounts

					31.12.21	31.12.20
			Unrestricted	Restricted	Total	Total
			fund	fund	funds	funds
		Notes	f
INCOME AND ENDOWMENTS FROM
Charitable activities
To advance the science	and art ofgynaecological
oncology for the benefit ofthe public			218,991		218)991	51,532
Investment income			14		14	144
Other income			553		553
Total			219,558		219,558	51,676
EXPENDITURE ON
Charitable activities		4
To advance the science	and art ofgynaecological
oncology for the benefit ofthe public			88,013		88,013	77,229
NET INCOME/(EXPENDITURE)			131,545		131,545	(25,553)
RECONCILIATION	OF FUNDS
Total funds brought forward			441,466		441,466	467,019
TOTAL FUNDS CARRIED FORWARD			573,011		573,011	441,466

				31.12.21	31.12.20
		Unrestricted	Restricted	Total	Total
		fund	fund	funds	funds
	Notes		f,	8
CURRENT ASSETS
Debtors	9	107,379		107,379	2,040
Cash at bank		476,082		476,082	453,469
		583,461		583,461	455,509
CREDITORS
Amounts falling due within one year	10	(10,450)		(10,450)	(14,043)
NET CURRENT ASSETS		573,011		573,011	441,466
TOTAL ASSETSLESSCURRENT
LIABILITIES		573,011		573,011	441,466
NET ASSETS		573,011		573,011	441,466
FUNDS
Unrestricted funds				573,011	441,466
TOTAL FUNDS				573,011	441,466

3.	INCOME FROM CHARITABLE ACTIVITIES	INCOME FROM CHARITABLE ACTIVITIES	INCOME FROM CHARITABLE ACTIVITIES	INCOME FROM CHARITABLE ACTIVITIES	INCOME FROM CHARITABLE ACTIVITIES	INCOME FROM CHARITABLE ACTIVITIES
							31.12.21	31.12.20
					Activity
					To advance the	science and art of
					gynaecological	oncology for the benefit of
	Sponsorships				the public		88,400	6,883.
					To advance the	science and art of
					gynaecological	oncology for the benefit of
	Delegate fees				the public		$1)285	785
					To advance the	science and art of
					gynaecological	oncology for the benefit of
	Subscriptions				the public		49,306	43,864
							218,991	51,532
4.	CHARITABLE			ACTIVITIES COSTS
							Support
						Direct	costs (see
						Costs	note 5)	Totals
	To advance	the	science and art of
	gynaecological		oncology		for the benefit
	ofthe public					69,653	18,360	8$,013
5.	SUPPORT	COSTS
							Governance
						Management	costs f	Totals
	To advance	the	science and art of
	gynaecological		oncology		for the benefit of
	the public					16,281	2,079	1$,360
6.	INDEPENDENT			EXAMINER'S FEES
							31.12.21	31.12.20
							f
	Independent	examiner's			fees		2,079	1,500
	Other assurance		services					500

ended 31 December 20	20.
Trustees' expenses
				31.12.21	31.12.20
				8
Trustees' expenses					516
COMPARATIVES FORTHE STATEMENT OF FINANCIAL ACTIVITIES
			Unrestricted	Restricted	Total
			fund	fund	funds
			f	f,
INCOME AND ENDOWMENTS		FROM
Charitable activities
To advance the science	and art of
gynaecological oncology for the benefit ofthe
public			51,532		51,532
Investment income					144
Total			51,676		51,676
EXPENDITURE ON
Charitable activities
To advance the science	and art of
gynaecological oncology for the benefit ofthe
public			77,229		77,229
NET INCOME/(EXPENDITURE)			(25,553)		(25,553)
RECONCILIATION	OF FUNDS
Total funds brought forward			467,019		467,019
TOTAL FUNDS CARRIED FORWARD			441,466		441,466

9.	DEBTORS:	AMOUNTS FALLING DUE WITHIN ONE YEAR	AMOUNTS FALLING DUE WITHIN ONE YEAR	AMOUNTS FALLING DUE WITHIN ONE YEAR
					31.12.21	31.12.20
						f
	Other debtors				105,032
	Prepayments				2,347	2,040
					107,379	2,040
10.	CREDITORS:		AMOUNTS FALLING DUE WITHIN ONE YEAR
					31.12.21	31.12.20
	VAT				7,260	1,289
	Other creditors				1,191	11,254
	Accrued expenses				1,999	1,500
					10,450	14,043
11.	MOVEMENT		IN FUNDS
					Net
					movement	At
				At 1.1.21	in funds	31.12.21
						f
	Unrestricted	funds
	General fund			441,466	131,545	573,011
	TOTAL FUNDS			441,466	131,545	573,011
	Net movement		in funds, included	in the above are as follows:
				Incoming	Resources	Movement
				resources	expended	in funds
	Unrestricted	funds
	General fund			219,558	(88,013)	131,545
	TOTAL FUNDS			219,558	(88,013)	131,545

				Net
				movement	At
			At 1.1.20	in funds	31.12.20
				6
Unrestricted	funds
General fund			467,019	(25,553)	441,466
TOTAL FUNDS			467,019	(25,553)	441,466
Comparative	net movement	in funds, included	in the above are as follows:
			Incoming	Resources	Movement
			resources	expended	in funds
Unrestricted	funds
General fund			51,676	(77,229)	(25,553)
TOTAL FUNDS			51,676	(77,229)	(25,553)

			Net
			movement	At
		At 1.1.20	in funds	31.12.21
			f
Unrestricted	funds
General fund		467,019	105,992	573,011
TOTAL FUNDS		467,019	105,992	573,011

			Incoming	Resources	Movement
			resources	expended	in funds
Unrestricted		funds
General	fund		271,234	(165,242)	105,992
TOTAL	FUNDS		271,234	(165,242)	105,992